Menú
Skills en este repositorio
SkillsMP ha recopilado 858 skills de dromlakhani/MD2SKILL. Abre una skill para revisar su origen y sus detalles.
dromlakhani/MD2SKILLMostrando 40 de 858 skills recopiladas.
This skill suggests genetic testing for pediatric patients with extreme early onset obesity (onset before 5 years of age) who exhibit clinical features of genetic obesity syndromes such as extreme hyperphagia, or who have a family history of extreme obesity.…
Idioma del texto original: inglés
Interprets HbA1c to screen for prediabetes and diabetes in overweight or obese children (BMI ≥85th percentile) being evaluated for comorbidities. Triggers include HbA1c results, BMI percentile, and clinical suspicion of dysglycemia.
Idioma del texto original: inglés
Interprets HDL cholesterol levels to screen for dyslipidemia in pediatric patients using thresholds of <40 mg/dL low, 40–45 mg/dL borderline low, and ≥45 mg/dL acceptable. Triggered during lipid panel review for overweight or obese children (BMI ≥85th…
Idioma del texto original: inglés
Prescribes specific healthy eating habits for pediatric obesity prevention and treatment, focusing on avoiding calorie-dense nutrient-poor foods and encouraging whole fruits over juice. Trigger phrases include well-child visit, BMI ≥85th percentile, excessive…
Idioma del texto original: inglés
Diagnoses obesity in infants and toddlers under 2 years of age when sex-specific weight-for-recumbent length is at or above the 97.7th percentile on WHO growth charts. Consider this assessment during well-child visits when caregivers report excessive weight…
Idioma del texto original: inglés
Interprets LDL cholesterol levels to screen for dyslipidemia in children and adolescents with obesity (BMI ≥85th percentile). Acceptable <110 mg/dL, borderline high 110-129 mg/dL, high ≥130 mg/dL triggers further evaluation or lifestyle intervention.
Idioma del texto original: inglés
Interprets the 2-hour plasma glucose from an oral glucose tolerance test (OGTT) to screen for prediabetes and diabetes in children and adolescents with overweight or obesity. Uses thresholds of <140 mg/dL (normal), 140–199 mg/dL (impaired glucose tolerance,…
Idioma del texto original: inglés
Interprets free and total testosterone and SHBG levels to screen for hyperandrogenism in adolescents with obesity, using Endocrine Society PCOS guidelines. Trigger phrases include oligomenorrhea, hirsutism, acne, and elevated androgen symptoms prompting PCOS…
Idioma del texto original: inglés
Determines when to administer FDA-approved obesity pharmacotherapy in pediatric patients, requiring a concomitant lifestyle modification program of the highest intensity and prescribing only by experienced clinicians. Triggers include documented failure of…
Idioma del texto original: inglés
Determines when to discontinue obesity pharmacotherapy due to lack of efficacy. Trigger phrases include “<4% BMI/BMI z score reduction after 12 weeks at full dosage” or “insufficient weight loss on antiobesity medication.”
Idioma del texto original: inglés
Determines when to initiate pharmacotherapy for pediatric obesity after a formal intensive lifestyle modification program fails to limit weight gain or ameliorate comorbidities. Trigger phrases include "failed intensive lifestyle modification," "no weight…
Idioma del texto original: inglés
Prescribes physical activity for pediatric obesity prevention and treatment in children and adolescents with BMI at or above the 85th percentile. Recommends at least 20 minutes, optimally 60 minutes, of vigorous physical activity on ≥5 days per week to…
Idioma del texto original: inglés
This skill guides clinicians to evaluate for psychosocial comorbidities in pediatric obesity and to initiate assessment/counseling when psychosocial problems are suspected. Trigger phrases include family dysfunction, stressors, bullying, low self-esteem,…
Idioma del texto original: inglés
This skill guides clinicians to identify maladaptive rearing patterns related to diet, activity, and screen time in pediatric patients with overweight or obesity. It prompts evaluation of screen time, dietary habits, physical activity, and family eating cues…
Idioma del texto original: inglés
Recommends limiting non-academic screen time to 1-2 hours per day and decreasing other sedentary behaviors. Trigger phrases include "excessive screen time," "digital activities," and "sedentary behaviors."
Idioma del texto original: inglés
This skill interprets fasting total cholesterol levels to screen for dyslipidemia in children and adolescents undergoing obesity evaluation. Triggered by pediatric obesity screening (BMI ≥85th percentile) or dyslipidemia evaluation, it classifies cholesterol…
Idioma del texto original: inglés
Interprets fasting triglyceride levels to screen for dyslipidemia in children aged 0–9 years during obesity evaluation. Triggered by BMI ≥85th percentile, well-child visit, or concern for metabolic comorbidity.
Idioma del texto original: inglés
Interprets fasting triglyceride levels to screen for dyslipidemia in overweight or obese children aged 10-19 years. Triggered by pediatric obesity screening, fasting lipid panel, or BMI ≥85th percentile with clinical concern for dyslipidemia.
Idioma del texto original: inglés
Recommends low-dose GH replacement in patients with cured acromegaly and documented GHD in the absence of known contraindications. Triggers include managing a cured acromegaly patient with documented growth hormone deficiency.
Idioma del texto original: inglés
Recommends careful DDAVP and fluid intake titration including frequent weighing and serum sodium level monitoring for adipsic diabetes insipidus. Use when managing adipsic DI requiring fluid balance management.
Idioma del texto original: inglés
This skill recommends monitoring desmopressin (DDAVP) doses and adjusting them as needed in patients who have recently started antiepileptic drugs (AEDs). It is triggered when a patient initiates AED therapy and requires DDAVP management for diabetes…
Idioma del texto original: inglés
Evaluates central hypothyroidism (CH) patients for adrenal insufficiency (AI) prior to initiating levothyroxine (L‑T4) replacement. Triggers include consideration of L‑T4 start in central hypothyroidism needing thyroid replacement.
Idioma del texto original: inglés
Recommends treating central hypothyroidism before performing GH stimulation testing because CH may impair accurate diagnosis of GHD. Use when preparing for GH stimulation testing; triggers include patient requiring GH stimulation test with possible CH.
Idioma del texto original: inglés
This skill confirms central hypothyroidism when serum free T4 is below the laboratory reference range with low, normal, or mildly elevated TSH in the setting of pituitary disease. Use when assessing thyroid function in pituitary disease; triggers include…
Idioma del texto original: inglés
Recommend against using levotriiodothyronine (L-T3), thyroid extracts, or other thyroid hormone formulations for central hypothyroidism. Triggered when evaluating thyroid hormone replacement in central hypothyroidism (e.g., 'considering thyroid hormone…
Idioma del texto original: inglés
Individualizes desmopressin (DDAVP) therapeutic schedules for diabetes insipidus, educates patients on overdose risk, and recommends a weekly polyuria phase to assess medication wear‑off. Triggered when initiating DDAVP for diabetes insipidus (e.g., “Use when…
Idioma del texto original: inglés
Manages post-pituitary surgery diabetes insipidus (DI) to assess recovery of posterior pituitary function. Triggers include managing DI after pituitary surgery requiring assessment of posterior function via DDAVP discontinuation trial.
Idioma del texto original: inglés
Recommends that all diabetes insipidus patients wear an emergency bracelet or necklace to alert clinicians to their condition if incapacitated. Use when establishing care for a diabetes insipidus patient; triggers include diabetes insipidus diagnosis.
Idioma del texto original: inglés
This skill guides the simultaneous measurement of serum and urine osmolarity to evaluate polyuria for central diabetes insipidus. It is triggered when a patient presents with polyuria exceeding 50 mL/kg/24 hours or 3.5 L/day in a 70‑kg individual.
Idioma del texto original: inglés
Monitors fT4 levels and adjusts levothyroxine dose to maintain fT4 within the target range when central hypothyroidism patients require changes in estrogen therapy. Triggers include initiating, stopping, or adjusting estrogen therapy (oral or transdermal) in…
Idioma del texto original: inglés
This skill recommends against using growth hormone (GH) to enhance athletic performance, as the practice is illegal, lacks scientific or ethical justification, and has no substantiated efficacy. It is triggered when a patient requests GH for athletic…
Idioma del texto original: inglés
Recommends against biochemical testing for adult growth hormone deficiency when patients exhibit clear-cut features of GHD alongside three or more documented pituitary hormone deficits. Triggers when evaluating a patient with apparent GHD and multiple hormone…
Idioma del texto original: inglés
Uses BMI-specific cutoffs to interpret peak GH values during stimulation testing. Use when interpreting GH stimulation test results; triggers include GH stimulation test requiring BMI-adjusted interpretation.
Idioma del texto original: inglés
Monitors euthyroid adults with growth hormone deficiency (GHD) who are initiating GH replacement therapy for the development of central hypothyroidism (CH). Initiates levothyroxine (L-T4) if free thyroxine (fT4) falls below the laboratory reference range;…
Idioma del texto original: inglés
Calculates the initial growth hormone (GH) replacement dose based on patient age for adults with proven growth hormone deficiency (GHD). Triggers include initiating GH replacement in patients with proven GHD requiring GH replacement.
Idioma del texto original: inglés
Recommends against administering growth hormone to elderly adults who have age-adjusted low IGF-1 levels and no history of pituitary or hypothalamic disease. Triggered when considering GH replacement in an elderly patient with low IGF-1 (e.g., 'elderly…
Idioma del texto original: inglés
Suggests discontinuing growth hormone (GH) replacement during pregnancy due to lack of clear evidence for efficacy or safety and placental GH production. Triggers include managing a pregnant patient on GH replacement.
Idioma del texto original: inglés
Recommends GH stimulation testing for patients with suspected growth hormone deficiency (GHD). Triggers include evaluating a patient for suspected GHD when single GH measurements are not helpful.
Idioma del texto original: inglés
Titrates GH replacement dose to keep IGF-1 below the upper limit of normal and reduces dose when side effects appear. Use when monitoring GH replacement therapy; triggers include patient on GH replacement needing dose adjustment.
Idioma del texto original: inglés
Recommends against performing dynamic GnRH stimulation testing in the evaluation of hypogonadism, as it provides no additional diagnostic information beyond baseline gonadotropins and sex steroids. Consider this recommendation when evaluating hypogonadism and…
Idioma del texto original: inglés